"Le centre hospitalier de Béziers est l'établissement de santé de référence du Groupement Hospitalier de Territoire (GHT) Ouest-Hérault. 5e de la région Occitanie, il assure des missions de soins, d'enseignement et de formation."

During the past decade, Ch De Beziers; Hematologie conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ch De Beziers; Hematologie" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "BeiGene" with 1 trials as a collaborator and "Janssen-Cilag Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Ch De Beziers; Hematologie" are "Acute Myeloid Leukemia" (2 trials), "Breast Cancer" (1 trials), "CLL/SLL" (1 trials) and "Richter Syndrome" (1 trials). Many other conditions were trialed in "Ch De Beziers; Hematologie" in a lesser frequency.

Most popular intervention types in "Ch De Beziers; Hematologie" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Blinatumomab" (1 trials), "Cytarabine-Idarubicin Association" (1 trials), "Cytarabine-Venetoclax Association" (1 trials), "Dexamethasone" (1 trials) and "First line therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ch De Beziers; Hematologie" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ch De Beziers; Hematologie". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ch De Beziers; Hematologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ch De Beziers; Hematologie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".